Zhonghe Capital
Overview
Zhonghe Capital is a private equity and venture capital firm that focuses on investments in private placements of listed companies, mergers and acquisitions, convertible bonds, secondary markets, and unlisted company equity.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Moore Thread | Nov 2023 | Series B Extension | Co-investor |
| Linkerbot | Feb 2026 | Series B | Co-investor |
| Qianxun SI | Apr 2025 | Series B | Co-investor |
| Nanjing Zaiming Pharmaceutical Co., Ltd. | Jun 2025 | Series A | Co-investor |
| Hunan Norchem Pharmaceutical | Dec 2023 | Growth Equity | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Zhonghe Capital based?
Zhonghe Capital is headquartered in Beijing, China.
When was Zhonghe Capital founded?
Zhonghe Capital was founded in 2012.
How many portfolio companies does Zhonghe Capital have?
Zhonghe Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Zhonghe Capital's portfolio?
Portfolio companies visible on Caplight include Moore Thread, Linkerbot, Qianxun SI, Nanjing Zaiming Pharmaceutical Co., Ltd., Hunan Norchem Pharmaceutical.
What was Zhonghe Capital's most recent investment shown here?
Zhonghe Capital's most recent investment in this portfolio sample was in Linkerbot in 2026.
What sectors does Zhonghe Capital focus on?
Zhonghe Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Mobility, Transportation & Logistics, Media, Entertainment & Gaming, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Zhonghe Capital focus on?
Zhonghe Capital typically invests at the Mid stage.
What is Zhonghe Capital's AUM?
Zhonghe Capital's assets under management are estimated at over $3.6B.